Literature DB >> 4883430

Itil TM, Keskiner A, Fink M: Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia.

J M Holden.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4883430     DOI: 10.1016/s0010-440x(68)80059-8

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


× No keyword cloud information.
  8 in total

1.  Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.

Authors:  Hadar Zaman; Roger Carl Gibson; Geoffrey Walcott
Journal:  Cochrane Database Syst Rev       Date:  2019-08-05

2.  Benzodiazepines in the treatment of depressive, borderline personality, and schizophrenic disorders.

Authors:  A F Schatzberg; J O Cole
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

Review 3.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

4.  Hallucinations and delusions in black psychiatric patients.

Authors:  V R Adebimpe; H E Klein; J Fried
Journal:  J Natl Med Assoc       Date:  1981-06       Impact factor: 1.798

5.  Benzodiazepines in psychotic States.

Authors:  J Ananth; O Solano
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

Review 6.  Benzodiazepines for schizophrenia.

Authors:  Markus Dold; Chunbo Li; Magdolna Tardy; Vesal Khorsand; Donna Gillies; Stefan Leucht
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14

Review 7.  Thioridazine for schizophrenia.

Authors:  M Fenton; J Rathbone; J Reilly; A Sultana
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

8.  Treatment of the special patient with schizophrenia.

Authors:  R R Conley; D L Kelly
Journal:  Dialogues Clin Neurosci       Date:  2001-06       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.